Status:
COMPLETED
Warfarin Patient Self-Monitoring
Lead Sponsor:
University of British Columbia
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Atrial Fibrillation is a heart condition in which people are treated with blood thinners such as warfarin to decrease the risk of stroke. Large studies have shown that when patients adjust their own d...
Detailed Description
BACKGROUND Oral anticoagulants have seen large popularity due to their ease of administration and proven benefit in a variety of conditions. In an examination of patients in Manitoba, 7.2% of the elde...
Eligibility Criteria
Inclusion
- Over 18 years of age
- Anticoagulation to a target of 2.0-3.0
- Warfarin treatment for \> 3 months
- previous medication treatment adherence
- competence judged by demonstrable ability to utilize drug adjustment nomograms
- understand the basic theory of anticoagulation therapy
Exclusion
- Coagulopathic disease
- significant psychiatric illness
- significant language barrier
- poor visual acuity
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2010
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00925028
Start Date
July 1 2009
End Date
March 1 2010
Last Update
March 8 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gaetz Family Practice
Chilliwack, British Columbia, Canada, V2R 3P1